Illumina, Solexa Inc. deal

Microarray and genetic services company ILMN announced plans to acquire SLXA for $14 per share, or $600 million

Read the full 184 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE